A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

by | Oct 20, 2025 | Clinical Trials | 0 comments

​ Conditions: Chronic Lymphocytic Leukemia; Lymphoma, Small Lymphocytic

Interventions: Drug: Pirtobrutinib; Drug: Idelalisib

Sponsors: Eli Lilly and Company

Not yet recruiting Conditions: Chronic Lymphocytic Leukemia; Lymphoma, Small Lymphocytic
Interventions: Drug: Pirtobrutinib; Drug: Idelalisib
Sponsors: Eli Lilly and Company
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *